Financial Performance - The group recorded revenue of approximately SGD 7.9 million for the nine months ended September 30, 2023, an increase of about 18.1% compared to SGD 6.5 million for the same period last year [5]. - Gross profit for the period was approximately SGD 5.2 million, up about 22.5% from SGD 4.2 million in the previous year, primarily due to the lifting of Covid-19 restrictions in Singapore [6]. - The group reported a lower net loss of approximately SGD 0.4 million for the period, compared to a net loss of SGD 1.2 million in the same period last year [6]. - The group reported a comprehensive loss of approximately SGD 424.5 million for the nine months ended September 30, 2023, compared to a loss of SGD 1.18 million in the same period last year [11]. - For the nine months ended September 30, 2023, the group's revenue increased by approximately SGD 1.2 million or 18.1% to approximately SGD 7.9 million compared to the same period in 2022 [26]. - For the three months ended September 30, 2023, the group's revenue increased by approximately SGD 0.2 million or 7.8% to approximately SGD 2.5 million compared to the same period in 2022 [29]. - The group reported a basic loss per share of SGD (0.03) for the three months ended September 30, 2023, compared to a profit of SGD 0.01 in the same period of 2022 [22]. - The group incurred a loss attributable to owners of the company of SGD (158,641) for the three months ended September 30, 2023, compared to a profit of SGD 32,350 in the same period of 2022 [22]. Operational Insights - The group experienced a significant increase in patient numbers as foreign patients returned to seek timely and quality medical care in Singapore [6]. - Revenue from treatment services, medical examination services, and consultation services for the nine months ended September 30, 2023, were approximately SGD 4.6 million, SGD 2.0 million, and SGD 1.0 million, accounting for approximately 58.7%, 24.8%, and 13.3% of total revenue, respectively [26]. - The group anticipates that the demand for its clinic services may return to pre-pandemic levels due to the lifting of Covid-19 related restrictions and the relaxation of global travel limitations [29]. - The group operates five DTAP clinics located in Robertson, Novena, Holland Village, Kovan, and Paragon as of the report date [27]. Financial Position - The group’s total equity as of September 30, 2023, was approximately SGD 13.69 million, down from SGD 15.59 million at the beginning of the year [11]. - As of September 30, 2023, the group's cash and cash equivalents were approximately SGD 11 million, up from SGD 10 million as of December 31, 2022 [37]. - The capital debt ratio as of September 30, 2023, was approximately 9.5%, an increase from 5.7% as of December 31, 2022 [38]. - The group had no significant contingent liabilities as of September 30, 2023 [42]. Strategic Outlook - The group plans to expand its business model through strategic partnerships and regional outreach to provide more accessible healthcare services [27]. - The company remains cautiously optimistic about the business environment despite signs of improvement, due to potential negative impacts from various external factors [6]. - The group maintains a cautiously optimistic outlook amid geopolitical uncertainties and inflation threats, focusing on enhancing business revenue and profitability [27]. Corporate Governance - The board has resolved not to declare any dividends for the period, consistent with the previous year [7]. - The Audit Committee, consisting of three independent non-executive directors, reviewed the unaudited consolidated financial statements and found them compliant with applicable accounting standards [64]. - No directors or controlling shareholders have interests in any competing businesses during the period [62]. - The company has no outstanding stock options as of September 30, 2023, indicating no dilution of shares from options [56]. - The company did not redeem any of its listed securities during the period [63]. - The company has not purchased or sold any of its listed securities during the reporting period [63]. - There were no significant investments or acquisitions during the three-month period ending September 30, 2023 [41]. - The group has not recognized any overseas profits tax for entities registered in the British Virgin Islands or Cayman Islands due to tax exemptions [19].
REPUBLIC HC(08357) - 2023 Q3 - 季度财报